Leap Therapeutics corporate office is located in 47 Thorndike St Ste B1-1, Cambridge, Massachusetts, 02141, United States and has 51-200 employees.
leap therapeutics inc
leap therapeutics
leap therapeutics| inc
leap therapeutics ltd
leap pharmaceuticals llc
leap llc
Departments
Number of employees
C-Suite
3
Engineering & Technical
2
Operations
1
Finance
1
| Location | People at location |
| North America | 1-10 |
| Asia | 1-10 |
Explore people who held key positions, contributed to Leap Therapeutics's success, and advanced their careers.
Senior Manager, Extern... at uniQure
Worked as Associate Director, Quality Assurance
at Leap Therapeutics (2023-2025)
Chief Medical Officer at Compass Therapeutics
Worked as Chief Medical Officer
at Leap Therapeutics (2012-2025)
Head of Quality Senior... at Draig Therapeutics
Worked as Head of Quality Senior Director, Quality Assur...
at Leap Therapeutics (2021-2022)
Senior Director, Quali... at Ocular Therapeutix
Worked as Associate Director, CMC Analytical Development...
at Leap Therapeutics (2020-2023)
Vice President, Regula... at Nuvalent
Worked as Quality Vice President, Regulatory Affairs
at Leap Therapeutics (2020-2025)
Explore More
Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leaps most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. DKN-01 is being developed in patients with esophagogastric, gynecologic, and colorectal cancers. FL-301, is a humanized monoc... Read More